No takes yet. Share an insight, caveat, or question.
Preclinical study reveals that antigen avidity dictates B-cell competition and immunodominance in humanized mice, highlighting key principles for nanoparticle vaccine design.
Padilla et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: